Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Intraosseous spindle cell rhabdomyosarcoma characterized by the fusion of the EWSR1 or FUS gene with the TFCP2 gene, or the MEIS1 gene with the NCOA2 gene.
No clinical trials have been registered for intraosseous spindle cell rhabdomyosarcoma with TFCP2/NCOA2 rearrangements.
6 publications have been identified in PubMed for intraosseous spindle cell rhabdomyosarcoma with TFCP2/NCOA2 rearrangements. Research spans Case Report / Case Series (50%), Review / Meta-Analysis (33%), and Basic Science / Preclinical (17%).
Dankberg A (2026). [PMID: 41769942](https://pubmed.ncbi.nlm.nih.gov/41769942/). *Transl Vis Sci Technol*. [Review / Meta-Analysis]
Dehner CA (2025). [PMID: 41075874](https://pubmed.ncbi.nlm.nih.gov/41075874/). *Mod Pathol*. [Basic Science / Preclinical]
Shah A (2025). [PMID: 40716918](https://pubmed.ncbi.nlm.nih.gov/40716918/). *Surg Pathol Clin*. [Review / Meta-Analysis]
Chaudhury H (2025). [PMID: 41210564](https://pubmed.ncbi.nlm.nih.gov/41210564/). *Proc (Bayl Univ Med Cent)*. [Case Report / Case Series]
Plotzke JM (2024). [PMID: 38845135](https://pubmed.ncbi.nlm.nih.gov/38845135/). *Pediatr Dev Pathol*. [Case Report / Case Series]
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 9:49 PM UTC
Csizmok V (2024). [PMID: 39302072](https://pubmed.ncbi.nlm.nih.gov/39302072/). *Genes Chromosomes Cancer*. [Case Report / Case Series]